Biogen Learns Lessons From Lilly’s Failed Alzheimer’s Drug
Meanwhile, in other pharmaceutical news, the U.S. solicitor general urges the Supreme Court to review a case on biosimilars. And news outlets report on developments from Bristol-Myers, Horizon Pharma and Endo International.